| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/07/2006 | US6995299 Model system for Hepatitis C virus infection in humans, comprising non-human animal rendered immunologically tolerant to human hepatocytes and subsequently transplanted with human hepatocytes and infected with Hepatitis C |
| 02/07/2006 | US6995241 Acute Neuronal Induced Calcium-Binding Protein (ANIC-BP-1B) polypeptides and polynucleotides; diagnostic assays; neuroprotectants; agonists; antagonists; stroke , Parkinson's disease, Alzheimer disease, multiple sclerosis and spinal cord injuries |
| 02/07/2006 | US6995240 Treatment of inflammatory disease |
| 02/07/2006 | US6995140 Peptides and polypeptides useful for regenerating the nervous system |
| 02/07/2006 | US6995133 invention describes reduced synthesis of IFN alpha 5 in livers of patients with hepatitis C in comparison to healthy livers; demonstrates importance of use of such interferon sub-types in fabricating compositions for treating viral hepatopathies |
| 02/07/2006 | US6995015 Pathogen-resistant grape plants |
| 02/07/2006 | US6995013 Cell-scaffold composition containing five layers |
| 02/07/2006 | US6995011 Expression vector for use as tool in gene therapy |
| 02/07/2006 | US6995010 Two different adenoviral vectors for transferring a foreign gene into cell; a recombinase and a recombinase recognition sequence as the expression control system; improve efficiency of gene therapy; transformed cell |
| 02/07/2006 | US6995009 Virus-producing cell is used to produce retroviral vectors, for transfer the genes of interest into cells; produce infectious viruses at high titers, long-term stability and safety; prevent the emergence of wild type viruses |
| 02/07/2006 | US6995006 Incubating a producer cell in a cell culture medium; wherein the producer cell is other than a KB cell, whereby greater than about 102 particles are produced from the producer cell |
| 02/07/2006 | US6995004 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β 1,3-N-ACETYLGALACTOSAMINE-α-R / N-ACETYLGLUCOSAMINE-β 1,3,-N-ACETYLGALACTOSAMINE-α-R (GLCNAC TO GALNAC) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2/4GNT |
| 02/07/2006 | US6994999 Isolated DNA molecule comprising the promoter sequence of a bovine myostatin gene |
| 02/07/2006 | US6994996 polypeptide able to regulate ATPase activity; use treating various disease such as malignant tumors, hemopathies, HIV infections, immune diseases and inflammations |
| 02/07/2006 | US6994995 Specified sequences; expression vectors and host cells; share sequence similarity with mammalian synaptotagmins which have been implicated in membrane traffic and calcium dependent neuroexocytosis and are drug targets |
| 02/07/2006 | US6994994 Of the tumor necrosis factor receptor family; given amino acid sequence; use treating diseases and disorders ameliorated or cured by decreasing the levels of ligands of the original CD40R such as autoimmune diseases |
| 02/07/2006 | US6994993 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |
| 02/07/2006 | US6994991 Identification of differentially methylated multiple drug resistance loci |
| 02/07/2006 | US6994989 Fetal liver kinase 1 (flk-1), is a member of the type III subclass of receptor tyrosine kinase (RTK) family; specified amino acid and nucleotide sequences; expression vectors; expression by a host cell; modulators of angiogenesis |
| 02/07/2006 | US6994978 Human osteoclast derived cathepsin |
| 02/07/2006 | US6994977 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 02/07/2006 | US6994975 Expression and purification of ATM protein using vaccinia virus |
| 02/07/2006 | US6994957 Using nucleic acid |
| 02/07/2006 | US6994861 Antiprotozoa agents; parasiticides; prevention abortion in mammals |
| 02/07/2006 | US6994858 Infecting the mixed cellular compositions with reovirus which selectively lyse the ras-mediated neoplastic cells in the mixed composition |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994854 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 02/07/2006 | CA2340611C Defatted canola meal with reduced glucosilonate content |
| 02/07/2006 | CA1341494C Plants with modified stamen cells |
| 02/06/2006 | WO2006014162A2 Methods of using regenerative cells in the treatment of renal diseases and disorders |
| 02/02/2006 | WO2006012451A2 Compositions and methods of use for mgd-csf in disease treatment |
| 02/02/2006 | WO2006012404A2 Novel cell populations and uses thereof |
| 02/02/2006 | WO2006012359A2 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 02/02/2006 | WO2006012309A1 Inducible inactivation of synaptic transmission |
| 02/02/2006 | WO2006011682A1 Method of preserving and transporting lymphocytes |
| 02/02/2006 | WO2006011681A1 Preservation method and transport method for blood for leucocyte incubation, preservation method and transport method for peripheral blood monocytes and method of incubating leucocytes using the same |
| 02/02/2006 | WO2006011354A1 Cell fusion promoter and utilization of the same |
| 02/02/2006 | WO2006011296A1 Method of three-dimensionally culturing chondrocytes |
| 02/02/2006 | WO2006011061A2 Isolated muscle satellite cells, use thereof in muscle tissue repair and method for isolating said muscle satellite cells |
| 02/02/2006 | WO2006010834A1 Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 02/02/2006 | WO2006010727A2 Tridimensional support for cell culture, culture method making use of such a support and stem-like cells obtained through such a method |
| 02/02/2006 | WO2006010600A2 Stem cells obtained from pulp of deciduous or permanent teeth and of dental germ, able to produce human bone tissue |
| 02/02/2006 | WO2006010385A1 Vascular stem cells and uses thereof |
| 02/02/2006 | WO2005120222A3 Genetically modified non-human mammals and cells |
| 02/02/2006 | WO2005117989A9 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
| 02/02/2006 | WO2005115447A3 Human anti-cancer immunotherapy |
| 02/02/2006 | WO2005113748A3 Mapc generation of lung tissue |
| 02/02/2006 | WO2005094852A3 Sperm suspensions for use in insemination |
| 02/02/2006 | WO2005080544A3 Cell/tissue culturing device, system and method |
| 02/02/2006 | WO2005047490A3 Improvements in cell growth |
| 02/02/2006 | WO2005046445A3 Artificial tissue systems and uses thereof |
| 02/02/2006 | WO2004097004A3 Trasngenic expression of a phytochrome a gene |
| 02/02/2006 | WO2004058940A3 Sirna-mediated gene silencing |
| 02/02/2006 | WO2003102166A3 Novel flavivirus antigens |
| 02/02/2006 | WO2003093298A3 Immunogenic peptides |
| 02/02/2006 | WO2002094990A3 Receptors and membrane-associated proteins |
| 02/02/2006 | US20060026722 Millet cultivar gg102 |
| 02/02/2006 | US20060026720 Plant proteins |
| 02/02/2006 | US20060026719 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 02/02/2006 | US20060026717 nucleotide sequences or fragments, used for expressing heterologous proteins to the embryo tissue of monocotyledonous plants particularly cereals and corn |
| 02/02/2006 | US20060026715 Commercial production of polysaccharide degrading enzymes in plants and methods of using same |
| 02/02/2006 | US20060026713 Nucleotide sequences coding beta ketoacyl-acyl carrier protein synthase II for use in modifying fatty acid concentration in crop plants |
| 02/02/2006 | US20060026707 Isolated from Zea mays; transformed plant; can be used to repress the expression of a desired target gene in specific plant tissue or to prevent the repression of a particular desired target gene |
| 02/02/2006 | US20060026705 Plant amino acid biosynthetic enzymes |
| 02/02/2006 | US20060026704 Vector for the production of transplastomic angiosperm plants |
| 02/02/2006 | US20060026700 Tissue specific genes and gene clusters |
| 02/02/2006 | US20060026698 Transgenic transchromosomal rodents for making human antibodies |
| 02/02/2006 | US20060026696 Humanized immunoglobulin loci |
| 02/02/2006 | US20060025786 Method for autologous transplantation |
| 02/02/2006 | US20060025582 Promoter sequences for corticotropin releasing-factor receptor CRF2alpha and method of identifying agents that alter the activity of the promoter sequences |
| 02/02/2006 | US20060025576 Multivalent antibodies and uses therefor |
| 02/02/2006 | US20060025575 Hybridoma cell line producing monoclonal antibodies to bind to, to detect and qualitatively and quantitatively measure the presence of epitopes of prion proteins; neurodegenerative diseases of the central nervous system |
| 02/02/2006 | US20060025574 32 human secreted proteins |
| 02/02/2006 | US20060025573 Reducing the immunogenicity of fusion proteins |
| 02/02/2006 | US20060025572 Mammalian cell surface antigens; related reagents |
| 02/02/2006 | US20060025570 Megakaryocyte stimulating factors |
| 02/02/2006 | US20060025372 Antisense modulation of PTP1B expression |
| 02/02/2006 | US20060025362 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 02/02/2006 | US20060024829 Adenovirus packaging cell lines |
| 02/02/2006 | US20060024827 Stroma-free, serum-free, and chemically defined medium and method for ex vivo mononuclear cell expansion using the same |
| 02/02/2006 | US20060024826 Tympanic membrane patch |
| 02/02/2006 | US20060024825 Method of promoting expansion of stem cells |
| 02/02/2006 | US20060024824 Magnetic cell separation method |
| 02/02/2006 | US20060024823 Cell culture carriers, method for manufacturing cell culture carriers and method for culturing cells |
| 02/02/2006 | US20060024822 System and method for cultivating cells |
| 02/02/2006 | US20060024820 Chromosome-based platforms |
| 02/02/2006 | US20060024804 Isoforms isolated and purified from mammalian colostrum |
| 02/02/2006 | US20060024800 Method of modulating the activity of functional immune molecules |
| 02/02/2006 | US20060024798 Gene knockout; gene overexpression; liposomes |
| 02/02/2006 | US20060024796 Transcriptional activator gene for genes involved in cobalamin biosynthesis |
| 02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024788 Inducible alphaviral gene expression system |
| 02/02/2006 | US20060024785 Having mutations in the Kinase domain region (KDR) and/or the FMS-like Tyrosine-Kinase region (FLT-1), said variants exhibiting modified binding characteristics at said regions compared with native VEGF; stimulates vasculogenesis or angiogenesis; wound healing |
| 02/02/2006 | US20060024773 Method for measuring intracellular gene transcription using blue luciferase from dinoflagellate |
| 02/02/2006 | US20060024739 C. elegans gro-1 gene |
| 02/02/2006 | US20060024729 Mechanosensitive mammalian potassium channels activatable by polyunsaturated fatty acids and the use of said channels in drug screening |
| 02/02/2006 | US20060024728 GM-CSF and/or defensin protein expression regulators in epithelial cells comprising ETS transcription factor or gene encoding the same |
| 02/02/2006 | US20060024693 for the identification of "pregnancy competent" oocytes; identifying female subjects, preferably human females having impaired fertility function; evaluating the efficacy of a putative fertility treatment |
| 02/02/2006 | US20060024666 Humanized antibodies against the venezuelan equine encephalitis virus |